Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Two (2) dose levels of Proellex or placebo will be administered once-daily for up to 91 days. Following screening and a pre-treatment endometrial biopsy, subjects will be followed monthly for the three month treatment phase.
Epistemonikos ID: e238ac3c26cca7277bfcb2fbd2683b0e88128d33
First added on: May 05, 2024